CoreValve Evolut R, intermediate risk patients, european approval, CE mark

August 4, 2016 — Medtronic announced CE (Conformité Européenne) mark market clearnace for the self-expanding, recapturable and repositionable CoreValve Evolut R System to treat aortic stenosis patients who are at intermediate risk for open-heart surgery. The Evolut R System is the first transcatheter aortic valve replacement (TAVR or TAVI) device to obtain this expanded indication in Europe.

As more procedures move into the cath lab, growing complexity is fueling an increase in procedural volume and the need to carry a larger, more diverse inventory. Automated technology can help you more effectively manage high-value devices, allowing you to streamline inventory, minimize expired products, and increase charge capture. 

 

To view the white paper from Cardinal Health, please complete the registration form below.

 
 

August 3, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance to Rex Medical’s bioresorbable Closer Vascular Sealing System (VSS) to achieve rapid hemostasis of femoral artery catheterizations. 

CT angiography, CTA, coronary CT, cardiac CT, SCCT, society of cardiovascular computed tomography, cardiac imaging

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting offers an in-depth review of all aspects of cardiac CT. The importance of the news from this conference is increasing each year as CT continues to see large expansion in the cardiovascular space, as recently found in a review of Medicare (CMS) data (read the article "Substantial Growth Found in Ordering of CTA Exams in Medicare Population"). 

August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates’ Gore Tigris Vascular Stent, a dual-component stent with a unique fluoropolymer / nitinol design. The Gore Tigris device, which gained CE mark approval in 2011, is a third generation, self-expanding stent. The device was designed explicitly to improve anatomical conformability with the natural movement of the knee when treating peripheral artery disease (PAD).

According to a new study, the last 13 years have seen substantial growth in the ordering of computed tomography angiography (CTA) examinations in the Medicare population, particularly in the emergency department (ED) setting.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now